Medibank just raised its dividend. Here's what you need to know

Medibank just raised its dividend for the sixth year in a row.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's a huge day for earnings on the ASX this Thursday. This session has seen a bevy of ASX 200 shares deliver their latest numbers to investors. We've heard from Telstra Group Ltd (ASX: TLS), Wesfarmers Ltd (ASX: WES) and Transurban Group (ASX: TCL). But I want to talk about Medibank Private Ltd (ASX: MPL) and the new dividend that was just revealed.

Yep, just like Telstra and Wesfarmers, Medibank reported its latest earnings to the markets this morning. As we covered, it was a mixed set of numbers that the ASX 200 private health insurance stock came up with.

Medibank reported a 5.5% rise in group revenues to $4.5 billion. Group operating profit increased 6% to $381.7 million, although underlying net profit after tax (NPAT) was effectively unchanged at $297.8 million.

Investors don't seem to be impressed, to be frank, with the Medibank Private share price, which is currently down a nasty 6.16% at $4.50 a share. Saying that, the company is essentially now back to where it was on Tuesday, before yesterday's near-6% share price spike. This spike came after news that the government will allow private health insurers to hike premiums by at least 4.41% from April. That's the largest premium increase Australians have seen in many years.

But let's dig into Medibank's new dividend announcement today.

Stethoscope with a piggy bank and hundred dollar notes.

Image source: Getty Images

Medibank shares slip despite dividend hike

In some pleasing news for income investors, Medibank has just revealed that it will hike its next dividend. The company revealed an interim dividend of 8.3 cents per share as its first payout of 2026. Like most dividends from Medibank Private, it will come with full franking credits attached.

This interim dividend represents a 6.4% increase over the 7.8 cents per share payout that Medibank doled out this time last year. Together with the final dividend of 10.2 cents per share from October last year, it takes Medibank's 12-month dividend total to 18.5 cents per share, a record high for the company.

It is a significant payout on another level for Medibank. This latest dividend is the sixth consecutive payout in a row that has been increased annually. That's quite a streak that Medibank is cultivating.

Medibank shares will trade ex-dividend for this payout on 26 February next week. Payday has then been scheduled for 18 March next month. Medibank is not running a dividend reinvestment plan for this dividend, so investors will have to take it in cash.

As it stands today, Medibank Private shares are trading on a trailing dividend yield of 4%. However, with this new payout revealed, we can give the stock a forward dividend yield of 4.11%.

Motley Fool contributor Sebastian Bowen has positions in Wesfarmers. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Transurban Group and Wesfarmers. The Motley Fool Australia has positions in and has recommended Telstra Group and Transurban Group. The Motley Fool Australia has recommended Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Shot of a young businesswoman looking stressed out while working in an office.
Healthcare Shares

Beaten down: Are Cochlear, Pro Medicus or CSL shares a better buy right now?

Which struggling healthcare stock could bounce back?

Read more »

A woman reclines in a comfortable chair while she donates blood holding a pumping toy in one hand and giving the thumbs up in the other as she is attached to a medical machine to collect her blood donation.
Healthcare Shares

How high does UBS think CSL shares will go?

This global company is way oversold analysts say.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Macquarie thinks this biotech company's shares could jump more than 50%

Strong royalty flows underpin a bullish valuation.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Growth Shares

3 ASX 200 shares tipped to climb 130% (or more) in the next 12 months

Analysts are bullish about the outlook for these shares.

Read more »

A man sitting at his desktop computer leans forward onto his elbows and yawns while he rubs his eyes as though he is very tired.
Healthcare Shares

Why is this ASX 200 stock sinking 6% today?

This stock is having a tough session. Let's find out what's going on.

Read more »

Portrait, confidence and team of doctors in the hospital standing after a consultation or surgery. Success, healthcare and group of professional medical workers in collaboration at a medicare clinic.
Healthcare Shares

The cutting edge ASX healthcare stock that could rise 50%

Why is the broker bullish on this stock?

Read more »

young female doctor with digital tablet looking confused.
Earnings Results

Neuren shares dip after FY25 result. Here's what stood out

Royalties rise at Neuren, but total income falls for FY25.

Read more »

A man rests his chin in his hands, pondering what is the answer?
Healthcare Shares

What's going on with Mesoblast shares today?

This biotech was up almost 9% before sinking into the red.

Read more »